Update information

Update information

November 2021: We withdrew recommendations 1.6.1 to 1.6.4 on valvular surgery and percutaneous intervention because they have been replaced by the NICE guideline on heart valve disease.

Minor changes since publication

March 2016: MHRA advice on spironolactone and renin-angiotensin system drugs added to recommendation 1.5.4.

ISBN: 978-1-4731-0780-9

  • National Institute for Health and Care Excellence (NICE)